Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade

Clinical trial NCT05037006 · UNKNOWN

Trial details

NCT number: NCT05037006
Sponsor: Pontificia Universidade Catolica de Sao Paulo
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blockade Neuromuscular Blockade, Residual

Start date: 2021-10-01
Primary completion: 2021-12-20
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.